249 related articles for article (PubMed ID: 27743341)
21. Association of SNCA with Parkinson: replication in the Harvard NeuroDiscovery Center Biomarker Study.
Ding H; Sarokhan AK; Roderick SS; Bakshi R; Maher NE; Ashourian P; Kan CG; Chang S; Santarlasci A; Swords KE; Ravina BM; Hayes MT; Sohur US; Wills AM; Flaherty AW; Unni VK; Hung AY; Selkoe DJ; Schwarzschild MA; Schlossmacher MG; Sudarsky LR; Growdon JH; Ivinson AJ; Hyman BT; Scherzer CR
Mov Disord; 2011 Oct; 26(12):2283-6. PubMed ID: 21953863
[TBL] [Abstract][Full Text] [Related]
22. SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease.
Fernández-Santiago R; Martín-Flores N; Antonelli F; Cerquera C; Moreno V; Bandres-Ciga S; Manduchi E; Tolosa E; Singleton AB; Moore JH; ; Martí MJ; Ezquerra M; Malagelada C
Mov Disord; 2019 Sep; 34(9):1333-1344. PubMed ID: 31234232
[TBL] [Abstract][Full Text] [Related]
23. SNP rs7684318 of the alpha-synuclein gene is associated with Parkinson's disease in the Han Chinese population.
Yu L; Xu P; He X; Hu F; Lin Z; Zhu M; Liu Z; He L; Xu Y
Brain Res; 2010 Jul; 1346():262-5. PubMed ID: 20513365
[TBL] [Abstract][Full Text] [Related]
24. A comprehensive analysis of SNCA-related genetic risk in sporadic parkinson disease.
Pihlstrøm L; Blauwendraat C; Cappelletti C; Berge-Seidl V; Langmyhr M; Henriksen SP; van de Berg WDJ; Gibbs JR; Cookson MR; ; ; Singleton AB; Nalls MA; Toft M
Ann Neurol; 2018 Jul; 84(1):117-129. PubMed ID: 30146727
[TBL] [Abstract][Full Text] [Related]
25. Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson's disease.
Ross OA; Gosal D; Stone JT; Lincoln SJ; Heckman MG; Irvine GB; Johnston JA; Gibson JM; Farrer MJ; Lynch T
Mech Ageing Dev; 2007; 128(5-6):378-82. PubMed ID: 17531291
[TBL] [Abstract][Full Text] [Related]
26. Somatic copy number gains of α-synuclein (SNCA) in Parkinson's disease and multiple system atrophy brains.
Mokretar K; Pease D; Taanman JW; Soenmez A; Ejaz A; Lashley T; Ling H; Gentleman S; Houlden H; Holton JL; Schapira AHV; Nacheva E; Proukakis C
Brain; 2018 Aug; 141(8):2419-2431. PubMed ID: 29917054
[TBL] [Abstract][Full Text] [Related]
27. Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients.
Chiba-Falek O; Lopez GJ; Nussbaum RL
Mov Disord; 2006 Oct; 21(10):1703-8. PubMed ID: 16795004
[TBL] [Abstract][Full Text] [Related]
28. SNCA, LRRK2, MAPT polymorphisms and Parkinson's disease in Russia.
Emelyanov A; Andoskin P; Yakimovskii A; Usenko T; Nuzhnyi E; Nikolaev M; Pchelina S
Parkinsonism Relat Disord; 2013 Nov; 19(11):1064-5. PubMed ID: 23830801
[No Abstract] [Full Text] [Related]
29. [Frequency of single nucleotide polymorphisms and alpha-synuclein haplotypes associated with sporadic Parkinson's disease in the Mexican population].
Davila-Ortiz de Montellano DJ; Rodriguez-Violante M; Fresan A; Monroy-Jaramillo N; Yescas-Gomez P
Rev Neurol; 2016 Oct; 63(8):345-350. PubMed ID: 27699750
[TBL] [Abstract][Full Text] [Related]
30. The rs3756063 polymorphism is associated with SNCA methylation in the Chinese Han population.
Wei Y; Yang N; Xu Q; Sun Q; Guo J; Li K; Liu Z; Yan X; Zhu X; Tang B
J Neurol Sci; 2016 Aug; 367():11-4. PubMed ID: 27423554
[TBL] [Abstract][Full Text] [Related]
31. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
[TBL] [Abstract][Full Text] [Related]
32. Association of polymorphism in rs2736990 of the α-synuclein gene with Parkinson's disease in a Chinese population.
Pan F; Ding H; Dong H; Ye M; Liu W; Cui G; Chen J; Wu Y; Wang H; Dai X; Shi H; Ding X
Neurol India; 2013; 61(4):360-4. PubMed ID: 24005725
[TBL] [Abstract][Full Text] [Related]
33. Synaptotagmin XI in Parkinson's disease: New evidence from an association study in Spain and Mexico.
Sesar A; Cacheiro P; López-López M; Camiña-Tato M; Quintáns B; Monroy-Jaramillo N; Alonso-Vilatela ME; Cebrián E; Yescas-Gómez P; Ares B; Rivas MT; Castro A; Carracedo A; Sobrido MJ
J Neurol Sci; 2016 Mar; 362():321-5. PubMed ID: 26944171
[TBL] [Abstract][Full Text] [Related]
34. Calbindin 1, fibroblast growth factor 20, and alpha-synuclein in sporadic Parkinson's disease.
Mizuta I; Tsunoda T; Satake W; Nakabayashi Y; Watanabe M; Takeda A; Hasegawa K; Nakashima K; Yamamoto M; Hattori N; Murata M; Toda T
Hum Genet; 2008 Aug; 124(1):89-94. PubMed ID: 18568448
[TBL] [Abstract][Full Text] [Related]
35. [Molecular genetics of Parkinson's disease].
Toda T
Brain Nerve; 2007 Aug; 59(8):815-23. PubMed ID: 17713117
[TBL] [Abstract][Full Text] [Related]
36. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level.
Mata IF; Shi M; Agarwal P; Chung KA; Edwards KL; Factor SA; Galasko DR; Ginghina C; Griffith A; Higgins DS; Kay DM; Kim H; Leverenz JB; Quinn JF; Roberts JW; Samii A; Snapinn KW; Tsuang DW; Yearout D; Zhang J; Payami H; Zabetian CP
Arch Neurol; 2010 Nov; 67(11):1350-6. PubMed ID: 21060011
[TBL] [Abstract][Full Text] [Related]
37. Association between SNCA rs356220 polymorphism and Parkinson's disease: A meta-analysis.
Bi M; Kang S; Du X; Jiao Q; Jiang H
Neurosci Lett; 2020 Jan; 717():134703. PubMed ID: 31863812
[TBL] [Abstract][Full Text] [Related]
38. Cerebellar alpha-synuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material.
Westerlund M; Belin AC; Anvret A; Håkansson A; Nissbrandt H; Lind C; Sydow O; Olson L; Galter D
FASEB J; 2008 Oct; 22(10):3509-14. PubMed ID: 18606870
[TBL] [Abstract][Full Text] [Related]
39. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.
Elbaz A; Ross OA; Ioannidis JP; Soto-Ortolaza AI; Moisan F; Aasly J; Annesi G; Bozi M; Brighina L; Chartier-Harlin MC; Destée A; Ferrarese C; Ferraris A; Gibson JM; Gispert S; Hadjigeorgiou GM; Jasinska-Myga B; Klein C; Krüger R; Lambert JC; Lohmann K; van de Loo S; Loriot MA; Lynch T; Mellick GD; Mutez E; Nilsson C; Opala G; Puschmann A; Quattrone A; Sharma M; Silburn PA; Stefanis L; Uitti RJ; Valente EM; Vilariño-Güell C; Wirdefeldt K; Wszolek ZK; Xiromerisiou G; Maraganore DM; Farrer MJ;
Ann Neurol; 2011 May; 69(5):778-92. PubMed ID: 21391235
[TBL] [Abstract][Full Text] [Related]
40. The effect of SNCA 3' region on the levels of SNCA-112 splicing variant.
McCarthy JJ; Linnertz C; Saucier L; Burke JR; Hulette CM; Welsh-Bohmer KA; Chiba-Falek O
Neurogenetics; 2011 Feb; 12(1):59-64. PubMed ID: 21046180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
